Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

nytimes.com/2025/05/16/health/novo-nordisk-ceo-ozempic-wegovy.html

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

This story appeared on nytimes.com, 2025-05-16 13:58:02.
The Entire Business World on a Single Page. Free to Use →